Medical technology firms Abbott Laboratories and Stryker Corp. announced separate acquisitions with a combined value of $8.6 billion, aiming to further expand their portfolios beyond implanted devices and appeal to hospitals and clinics looking to bring down costs.
Read Full Article »
